Heterodimerization with β2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of α1D-Adrenergic Receptors

The α1D-adrenergic receptor (α1D-AR) is a G protein-coupled receptor (GPCR) that is poorly trafficked to the cell surface and largely nonfunctional when heterologously expressed by itself in a variety of cell types. We screened a library of approximately 30 other group I GPCRs in a quantitative luminometer assay for the ability to promote α1D-AR cell surface expression. Strikingly, these screens revealed only two receptors capable of inducing robust increases in the amount of α1D-AR at the cell surface: α1B-AR and β2-AR. Confocal imaging confirmed that coexpression with β2-AR resulted in translocation of α1D-AR from intracellular sites to the plasma membrane. Additionally, coimmunoprecipitation studies demonstrated that α1D-AR and β2-AR specifically interact to form heterodimers when coexpressed in HEK-293 cells. Ligand binding studies revealed an increase in total α1D-AR binding sites upon coexpression with β2-AR, but no apparent effect on the pharmacological properties of the receptors. In functional studies, coexpression with β2-AR significantly enhanced the coupling of α1D-AR to norepinephrine-stimulated Ca2+ mobilization. Heterodimerization of β2-AR with α1D-AR also conferred the ability of α1D-AR to cointernalize upon β2-AR agonist stimulation, revealing a novel mechanism by which these different adrenergic receptor subtypes may regulate each other's activity. These findings demonstrate that the selective association of α1D-AR with other receptors is crucial for receptor surface expression and function and also shed light on a novel mechanism of cross talk between α1- and β2-ARs that is mediated through heterodimerization and cross-internalization.

[1]  M. Romero-Ávila,et al.  Phosphorylation and desensitization of alpha1d-adrenergic receptors. , 2001, The Biochemical journal.

[2]  M. Caron,et al.  Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and ß-arrestin proteins , 2002, Progress in Neurobiology.

[3]  M. Scheinin,et al.  Receptor Subtype-Induced Targeting and Subtype-Specific Internalization of Human α2-Adrenoceptors in PC12 Cells , 1999, The Journal of Neuroscience.

[4]  D. Raju,et al.  Hetero-oligomerization between GABAA and GABAB Receptors Regulates GABAB Receptor Trafficking* , 2004, Journal of Biological Chemistry.

[5]  M. Torres-Padilla,et al.  Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat‐1 fibroblasts stably expressing α1d‐adrenoceptors , 1999, FEBS letters.

[6]  D. Zamanillo,et al.  Molecular Cloning of α1d‐Adrenergic Receptor and Tissue Distribution of Three α1‐Adrenergic Receptor Subtypes in Mouse , 1995 .

[7]  A. Kavelaars Regulated expression of alpha-1 adrenergic receptors in the immune system. , 2002, Brain, behavior, and immunity.

[8]  K. Ressler,et al.  Olfactory receptor surface expression is driven by association with the beta2-adrenergic receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Lembo,et al.  Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Lerner,et al.  Functional expression of olfactory-adrenergic receptor chimeras and intracellular retention of heterologously expressed olfactory receptors. , 1997, Brain research. Molecular brain research.

[11]  M. Cho,et al.  Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors , 1997, The Journal of Biological Chemistry.

[12]  M. Cho,et al.  Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling. , 1997, The Journal of biological chemistry.

[13]  B. Kobilka,et al.  Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. , 1997, Molecular pharmacology.

[14]  Joseph F. Williams Annual Review of Pharmacology , 1975 .

[15]  Christopher M. Tan,et al.  Membrane trafficking of G protein-coupled receptors. , 2004, Annual review of pharmacology and toxicology.

[16]  A. Baker,et al.  Alpha 1-adrenergic receptor responses in alpha 1AB-AR knockout mouse hearts suggest the presence of alpha 1D-AR. , 2003, American journal of physiology. Heart and circulatory physiology.

[17]  A. Kavelaars Regulated expression of α-1 adrenergic receptors in the immune system , 2002, Brain, Behavior, and Immunity.

[18]  B. Kobilka,et al.  Subtype-Specific Intracellular Trafficking of α2-Adrenergic Receptors , 1997 .

[19]  F. Marshall,et al.  GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.

[20]  G. Michelotti,et al.  Alpha 1-adrenergic receptor regulation: basic science and clinical implications. , 2000, Pharmacology & therapeutics.

[21]  G. Michelotti,et al.  α1-Adrenergic receptor regulation: basic science and clinical implications , 2000 .

[22]  T. Hökfelt,et al.  The distribution and significance of CNS adrenoceptors examined with in situ hybridization. , 1996, Trends in pharmacological sciences.

[23]  M. Piascik,et al.  α1B- and α1D-Adrenergic receptors exhibit different requirements for agonist and mitogen-activated protein kinase activation to regulate growth responses in Rat 1 fibroblasts , 2002 .

[24]  R. Lefkowitz,et al.  International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. , 1995, Pharmacological reviews.

[25]  G. Tsujimoto,et al.  Transgenic studies of α1-adrenergic receptor subtype function , 2002 .

[26]  N. Dzimiri Receptor crosstalk. Implications for cardiovascular function, disease and therapy. , 2002, European journal of biochemistry.

[27]  D. Moura,et al.  Vascular adrenoceptors: an update. , 2001, Pharmacological reviews.

[28]  G. Milligan,et al.  Cellular localization and pharmacological characterization of functioning alpha-1 adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors. , 1998, The Journal of pharmacology and experimental therapeutics.

[29]  N. Ryba,et al.  The Receptors for Mammalian Sweet and Umami Taste , 2003, Cell.

[30]  G. Tsujimoto,et al.  Transgenic studies of alpha(1)-adrenergic receptor subtype function. , 2002, Life sciences.

[31]  C. Hague,et al.  Cell Surface Expression of α1D-Adrenergic Receptors Is Controlled by Heterodimerization with α1B-Adrenergic Receptors* , 2004, Journal of Biological Chemistry.

[32]  T. K. Harden,et al.  Characterization of an altered membrane form of the beta-adrenergic receptor produced during agonist-induced desensitization. , 1983, The Journal of biological chemistry.

[33]  G. Tsujimoto,et al.  Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. , 2002, Molecular pharmacology.

[34]  K. Minneman,et al.  Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. , 1996, Molecular pharmacology.

[35]  J. Christianson,et al.  Regulation of Nicotinic Acetylcholine Receptor Assembly , 2003, Annals of the New York Academy of Sciences.

[36]  A. Vicentic,et al.  Biochemistry and Pharmacology of Epitope-Tagged α1-Adrenergic Receptor Subtypes , 2002 .

[37]  M. Piascik,et al.  alpha(1B)- and alpha(1D)-Adrenergic receptors exhibit different requirements for agonist and mitogen-activated protein kinase activation to regulate growth responses in rat 1 fibroblasts. , 2002, The Journal of pharmacology and experimental therapeutics.

[38]  K. Minneman,et al.  Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. , 2003, Molecular pharmacology.

[39]  A. Baker,et al.  α1-Adrenergic receptor responses in α1AB-AR knockout mouse hearts suggest the presence of α1D-AR , 2003 .

[40]  B. Kobilka,et al.  Cell-type Specific Targeting of the α2c-Adrenoceptor , 2000, The Journal of Biological Chemistry.

[41]  Cell-type specific targeting of the alpha 2c-adrenoceptor. Evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells. , 2000, The Journal of biological chemistry.

[42]  C. Hague,et al.  Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. , 2004, The Journal of biological chemistry.

[43]  Michel Bouvier,et al.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.

[44]  O. Valladares,et al.  α1d Adrenoceptor signaling is required for stimulus induced locomotor activity , 2003, Molecular Psychiatry.

[45]  Robert J. Lefkowitz,et al.  Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A , 1997, Nature.

[46]  M. Piascik,et al.  Regulation of the cellular localization and signaling properties of the alpha(1B)- and alpha(1D)-adrenoceptors by agonists and inverse agonists. , 2000, Molecular pharmacology.

[47]  S. Vatner,et al.  α- and β-Adrenergic Control of Large Coronary Arteries in Conscious Calves , 1990 .

[48]  D. Grandy,et al.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. , 2001, Molecular pharmacology.

[49]  H. Zhong,et al.  α1-Adrenoceptor subtypes , 1999 .

[50]  R. Graham,et al.  alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. , 1996, Circulation research.

[51]  M. Boutjdir,et al.  β- and α-adrenergic cross-signaling for L-type Ca current is impaired in transgenic mice with constitutive activation of εPKC , 2004 .

[52]  D. Zamanillo,et al.  Molecular cloning of alpha 1d-adrenergic receptor and tissue distribution of three alpha 1-adrenergic receptor subtypes in mouse. , 1995, Journal of neurochemistry.

[53]  A. Vicentic,et al.  Biochemistry and pharmacology of epitope-tagged alpha(1)-adrenergic receptor subtypes. , 2002, The Journal of pharmacology and experimental therapeutics.

[54]  F. Echeverri,et al.  Endoplasmic Reticulum Retention, Degradation, and Aggregation of Olfactory G‐Protein Coupled Receptors , 2003, Traffic.